N/A N=13 Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability
Vestibular Disorder · Dizziness
Primary: Difference in Dynamic Gait Index (DGI) — 0.77 units on a scale — p=0.018
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=2,583 Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders
Chronic Cerebral Ischemia
Primary: Mean MoCA Score at Week 1 and the End of the 12-week Therapy — 19.42; 24 score on a scale — p=<0.00001
Phase 4 N=135 Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Tardive Dyskinesia (TD)
Primary: Change From Randomization (Week 8) in Abnormal Involuntary Movement Scale (AIMS) Dyskinesia Total Score at Week 16 — 0.6; -1.6 Score on scale
Phase 3 N=351 A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
Actinic Keratosis
Primary: Percentage of Participants With Complete (100%) Clearance of Actinic Keratosis (AK) Lesions — 13; 54 percentage of participants — p=<0.0001
N/A N=120 Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
Lung Cancer · Gastric Cancer · Pancreatic Cancer
Primary: Clinical Trials Attitudes, Knowledge, and Interest — 4.6; 3.9; 4.9; 3.7 units on a scale — p=.307
N/A N=106 A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test
Sleep Apnea
Primary: Pearson Correlation Between the AHI — 0.909 Correlation coefficient
N/A N=294 Bifocal Lenses In Nearsighted Kids
Refractive Errors
Primary: Refractive Error Progression — -3.46; -3.32; -2.84 Diopters — p=<0.01
N/A N=24 Stroke Gait Rehabilitation Using Functional Electrical Stimulation
Cerebrovascular Accident
Primary: Change in Motor Evoked Potentials (MEP) Amplitude Measure in milliVolt (mV) of FastFES Versus Fast Walking After 3 Training Sessions in Cohort 2 — 0.058; 0.013 mV
Phase 2 N=48 Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants
Preterm Infants · Parenteral Nutrition n-3 Fatty Acids
Primary: Safety: Alanine Transaminase (ALT) — -0.83; -3.27 U/L — p=0.3654
Phase 2 N=50 Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
Herniorrhaphy · Postoperative Pain · Inguinal Hernia
Primary: Sum of Pain Intensity Defined as Area Under the Curve (AUC) of 100-mm VAS PI Scores. — 2810.4; 3484.5 score on a scale*hour
N/A N=400 Impact of Sugar-Sweetened Beverage Health Warnings
Dietary Habits
Primary: Mean Number of Calories (kcal) Purchased From Sugar-sweetened Beverages — 109.9; 143.2 kcal — p=0.02
Phase 3 N=134 Steroids for Pediatric Apnea Research in Kids
Obstructive Sleep Apnea Syndrome
Primary: Obstructive Apnea Hypopnea Index — 7.69; 6.33 events per hour
Phase 2 N=64 A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Primary: Mean Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) Improvement Compared to Placebo. — -6.2; -6.5; -6.2; -5.7 Scores on a scale — p=0.845
Phase 3 N=251 Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery
Pain Management
Primary: Adverse Events — 251 Participants
Phase 2 N=100 Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Arterial Occlusive Diseases · Coronary Artery Disease · Coronary Disease
Primary: First Occurrence of Major Plus Minor Thrombolysis in Myocardial Infarction (TIMI) Bleeding Events; Number/Percentage of Observed Participants With Outcome Measure Events…